Immune-response genes affecting breast tumor eradication
Presentations at the 4th IMPAKT Breast Cancer Conference
2012-05-04
(Press-News.org) Breast cancer patients whose tumors express high levels of genes related to immune response are more likely to have their tumor completely eradicated by pre-operative chemotherapy compared to patients with low expression of these genes, Belgian researchers report at the 4th IMPAKT Breast Cancer Conference in Brussels, Belgium.
Their research has identified a group of patients who might be good candidates for treatments with new immune-targeting therapies.
Dr Michail Ignatiadis from Institut Jules Bordet, Brussels, and colleagues analyzed gene expression data from eight studies in which patients had been treated with anthracyclines, with or without taxane chemotherapy, prior to surgery.
"We undertook this pooled analysis[1] to explore whether patients with different breast cancer subtypes respond differently to commonly used pre-operative chemotherapy, based on differences related to the cells of the tumor itself or to the non-tumor cells surrounding the tumor," Dr Ignatiadis explains.
To that end, the researchers analyzed the expression of distinct groups of genes, which they refer to as gene modules, that had been shown by other investigators to be associated with either important oncogenic pathways responsible for tumor cell proliferation or with the way the host immune system reacts to the tumor.
Patients whose tumors expressed high levels of gene modules related to immune system functions were more likely to have their tumor eradicated by the chemotherapy, they found.
"Patients with breast tumors that have high expression of genes related to immune response are more likely to present complete eradication of their tumor after the administration of commonly used pre-operative chemotherapy compared to patients with low expression of these genes. This was mainly observed in the so-called HER2-positive and less so in the ER-negative/HER2-negative and ER-positive/HER2-negative subtypes," said Dr Ignatiadis.
"The role of agents that modulate immune response in breast cancer should be studied, and in these trials patients should be optimally stratified based on their immune response," the researcher added. "Moreover, future studies should investigate whether the efficacy of anti-HER2 agents in HER2-positive early breast cancer patients is also associated with tumor immune response."
Commenting on this study, which he was not involved in, Dr Angelo Di Leo from the Hospital of Prato, Italy, former IMPAKT Chair, noted: "This study highlights the importance of the immune response of the patient as a major factor that can substantially impact treatment efficacy. It is quite clear that response to a given anti-cancer treatment may vary from one patient to another based also on the ability of the patient's immune system to aggress the tumor. This and other recently published studies pave the way to the development of a new generation of cancer drugs that can stimulate the immune response of the patient and make it more efficient in aggressing the tumor."
INFORMATION:
[1] J Clin Oncol. 2012 Apr 16.(http://www.ncbi.nlm.nih.gov/pubmed/22508827)
END
ELSE PRESS RELEASES FROM THIS DATE:
2012-05-04
Breast cancer in young women is a biologically unique disease that requires customized management strategies, researchers report at the 4th IMPAKT Breast Cancer Conference, in Brussels, Belgium.
The reported findings have potentially important implications for treatment, because breast cancer in young women is often aggressive and diagnosed at an advanced stage, meaning the prognosis for these patients is often poor.
Dr. Hatem A. Azim Jr., a medical oncologist from Institut Jules Bordet in Brussels, and colleagues showed that breast cancer in women forty-years or younger ...
2012-05-04
CHAPEL HILL, N.C. – Embryonic stem cells — those revered cells that give rise to every cell type in the body — just got another badge of honor. If they suffer damage that makes them a threat to the developing embryo, they swiftly fall on their swords for the greater good, according to a study published online May 3, 2012 in the journal Molecular Cell.
The finding offers a new glimpse into the private lives of stem cells that could help scientists use them to grow new neurons or other cells to replace those that have been lost in patients with Parkinson's and other diseases. ...
2012-05-04
May 3, 2012, New York, NY—The United States spends more on health care than 12 other industrialized countries yet does not provide "notably superior" care, according to a new study from The Commonwealth Fund. The U.S. spent nearly $8,000 per person in 2009 on health care services, while other countries in the study spent between one-third (Japan and New Zealand) and two-thirds (Norway and Switzerland) as much. While the U.S. performs well on breast and colorectal cancer survival rates, it has among the highest rates of potentially preventable deaths from asthma and amputations ...
2012-05-04
LA JOLLA, CA – May 3, 2012 - What genetic changes account for the vast behavioral differences between humans and other primates? Researchers so far have catalogued only a few, but now it seems that they can add a big one to the list. A team led by scientists at The Scripps Research Institute has shown that an extra copy of a brain-development gene, which appeared in our ancestors' genomes about 2.4 million years ago, allowed maturing neurons to migrate farther and develop more connections.
Surprisingly, the added copy doesn't augment the function of the original gene, ...
2012-05-04
PULLMAN, Wash.—Washington State University researchers have found that ovarian disease can result from exposures to a wide range of environmental chemicals and be inherited by future generations.
WSU reproductive biologist Michael Skinner and his laboratory colleagues looked at how a fungicide, pesticide, plastic, dioxin and hydrocarbon mixtures affected a gestating rat's progeny for multiple generations. They saw subsequent generations inherit ovarian disease by "epigenetic transgenerational inheritance." Epigenetics regulates how genes are turned on and off in tissues ...
2012-05-04
Patients in an intensive care unit (ICU) often become confused or delirious soon after, or within a few days of, admittance to the ICU. New research published in BioMed Central's open access journal Critical Care shows that use of earplugs can result in better sleep (as reported by the patients), lower the incidence of confusion, and delay the onset of cognitive disturbances.
Patients in the ICU are thought to suffer confusion and delirium due to sensory overload. Part of this is due to the physical injuries and sensations of the patients and part due to their environment. ...
2012-05-04
Researchers studying pigmentation in the South Pacific have uncovered a key genetic contribution to hair colour. The findings, published in Science, reveal a functional genetic variant which has led the islanders to have simultaneously the darkest skin pigmentation outside of Africa and the highest prevalence of blonde hair outside of Europe.
Human skin and hair colour varies considerably both within and among populations. Previous studies have shown that pigmentation is largely heritable but also suggest it has evolved to adapt to the sun's ultraviolet rays — with populations ...
2012-05-04
Alexandria, VA – The North Star, the Pole Star, the Guiding Star, Polaris: Its many names reflect the many centuries humans have gazed northward to it for guidance. However, recent studies have shown that the North Star is losing mass at a significant rate. Will Polaris, steadfast beacon for early sailors and adventurers alike, vanish from the night sky?
Hilding Neilson of the Argelander Institute of Astronomy at the University of Bonn in Germany thinks that he and his colleagues have unlocked the answer to the North Star's decreasing mass. Although the North Star's peculiar ...
2012-05-04
The latest cardiovascular disease (CVD) prevention guidelines have been overhauled to produce a user friendly document with concise messages that awards greater weight than ever before to evidence from clinical trials and observational population studies. The "European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (version 2012)" ¹ were launched at the EuroPRevent2012 meeting in Dublin, Ireland.
"In the past, implementation of prevention guidelines could undoubtedly have been better. So in a radical departure we've designed the guidelines in a ...
2012-05-04
Most people, whether healthy or having cardiovascular disease (CVD), would benefit from regular consumption of oily fish, concluded speakers at the EuroPRevent 2012 meeting. While eating whole fish undoubtedly offers the optimum approach for increasing omega-3 intakes in both primary and secondary prevention, delegates heard, supplements have a major role to play in increasing omega-3 intakes for people who do not like fish. The EuroPRevent 2012 meeting, held 3 May to 5 May 2012 in Dublin, Ireland, was organised by the European Association for Cardiovascular Prevention ...
LAST 30 PRESS RELEASES:
[Press-News.org] Immune-response genes affecting breast tumor eradication
Presentations at the 4th IMPAKT Breast Cancer Conference
